Stockscreener 앱 받기
3.42
6.81%
-0.25
시간 외 거래:
3.43
0.01
+0.29%
전일 마감가:
$3.67
열려 있는:
$3.71
하루 거래량:
2.79M
Relative Volume:
0.77
시가총액:
$369.03M
수익:
-
순이익/손실:
$-258.08M
주가수익비율:
-1.2436
EPS:
-2.75
순현금흐름:
$-202.32M
1주 성능:
+8.57%
1개월 성능:
+7.55%
6개월 성능:
-30.77%
1년 성능:
-79.34%
1일 변동 폭
$3.39
$3.73
1주일 범위
$3.10
$3.74
52주 변동 폭
$2.19
$18.89
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
명칭
Rocket Pharmaceuticals Inc
전화
646-440-9100
주소
350 FIFTH AVENUE, NEW YORK, NY
RCKT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.42 | 396.01M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-30 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-05-28 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-05-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-28 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-05-28 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2025-05-27 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-03-12 | 개시 | BMO Capital Markets | Outperform |
| 2024-12-30 | 개시 | Wedbush | Outperform |
| 2024-12-18 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-04-02 | 개시 | Goldman | Neutral |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 개시 | Morgan Stanley | Overweight |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2022-11-01 | 개시 | BTIG Research | Buy |
| 2022-07-08 | 개시 | Raymond James | Outperform |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 개시 | JP Morgan | Overweight |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2019-11-06 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-26 | 개시 | Piper Jaffray | Overweight |
| 2019-04-23 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-02-05 | 개시 | Oppenheimer | Outperform |
| 2018-09-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-10 | 개시 | William Blair | Outperform |
모두보기
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
Will Rocket Pharmaceuticals Inc. stock go up soonJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Should you hold or exit Rocket Pharmaceuticals Inc. now2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Published on: 2025-10-10 06:17:17 - newser.com
Published on: 2025-10-10 04:39:16 - newser.com
Building trade automation scripts for Rocket Pharmaceuticals Inc. Equity Warrant2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc. Equity WarrantMarket Volume Report & High Win Rate Trade Alerts - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock bottoming outJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
How sentiment analysis helps forecast Rocket Pharmaceuticals Inc. Equity WarrantPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock profit from fiscal stimulusEarnings Beat & Intraday High Probability Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Reach Out - ACCESS Newswire
How to manage a losing position in Rocket Pharmaceuticals Inc. Equity Warrant2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 05:44:17 - newser.com
Published on: 2025-10-09 03:18:17 - newser.com
Can a trend reversal in Rocket Pharmaceuticals Inc. Equity Warrant lead to recovery2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
Automated trading signals detected on Rocket Pharmaceuticals Inc. Equity WarrantWeekly Market Report & Safe Entry Point Identification - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Pass Below 50-Day Moving AverageWhat's Next? - MarketBeat
What drives Rocket Pharmaceuticals Inc stock priceBollinger Bands Signals & Free Dynamic Capital Growth - earlytimes.in
Rocket Pharmaceuticals Pulls BLA for Fanconi Anemia Gene Therapy RP-L102 - CGTLive®
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to global recession fearsJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock ready for a breakout2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant stock volume spike explainedPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Using AI based signals to follow Rocket Pharmaceuticals Inc. Equity WarrantMarket Performance Summary & Weekly High Conviction Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Combining price and volume data for Rocket Pharmaceuticals Inc. Equity WarrantEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Real time social sentiment graph for Rocket Pharmaceuticals Inc. Equity WarrantTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock positioned well for digital economyGap Up & Community Verified Trade Signals - newser.com
Understanding Rocket Pharmaceuticals Inc. Equity Warrant’s price movementJuly 2025 PreEarnings & Accurate Intraday Trade Tips - newser.com
Is now a turning point for Rocket Pharmaceuticals Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-10-05 06:51:42 - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock resilient to inflationMarket Activity Report & Real-Time Volume Spike Alerts - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy for dividend portfolios2025 Retail Activity & Safe Entry Zone Identification - newser.com
Comparing Rocket Pharmaceuticals Inc. Equity Warrant in custom built stock radarsJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Rocket Pharmaceuticals board member Pedro Granadillo resigns - StreetInsider
Leerink Partners Maintains Rocket Pharmaceuticals (RCKT) Market Perform Recommendation - Nasdaq
Rocket Pharmaceuticals announces board resignation of Pedro Granadillo - Investing.com
Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy - MedCity News
Rocket Pharmaceuticals (RCKT) Withdraws U.S. Filing for Gene The - GuruFocus
Leerink Partners Adjusts Rocket Pharmaceuticals Price Target to $7 From $9, Maintains Market Perform Rating - MarketScreener
Rocket Pharma pulls BLA for gene therapy RP-L102 in the USA - The Pharma Letter
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy - Stocktwits
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Cut to $7.00 by Analysts at Leerink Partners - MarketBeat
RCKT: Analyst Lowers Price Target for Rocket Pharmaceuticals | R - GuruFocus
Leerink Partners Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Announces Target Price $7 - 富途牛牛
Rocket Pharmaceuticals (RCKT) Halts U.S. Application for Gene Therapy - GuruFocus
Using R and stats models for Rocket Pharmaceuticals Inc. Equity Warrant forecasting2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Rocket Pharmaceuticals withdraws US application for blood disorder gene therapy - MarketScreener
Rocket Pharmaceuticals withdraws BLA for gene therapy RP-L102 in the US - Investing.com
Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder - Yahoo
Rocket Pharmaceuticals withdraws gene therapy application from FDA - StreetInsider
Will Rocket Pharmaceuticals Inc. rebound enough to break evenSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock outperform small cap peers2025 Buyback Activity & Target Return Focused Picks - newser.com
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rocket Pharmaceuticals Inc 주식 (RCKT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Militello John | See Remarks |
Aug 18 '25 |
Sale |
3.06 |
699 |
2,142 |
56,285 |
| Militello John | See Remarks |
Aug 19 '25 |
Sale |
3.00 |
361 |
1,082 |
55,924 |
| Schwartz Jonathan David | See Remarks |
Aug 18 '25 |
Sale |
3.06 |
1,680 |
5,149 |
222,414 |
| Schwartz Jonathan David | See Remarks |
Aug 19 '25 |
Sale |
3.00 |
805 |
2,412 |
221,609 |
| Wilson Martin | General Counsel |
Aug 18 '25 |
Sale |
3.06 |
1,004 |
3,077 |
136,050 |
| Wilson Martin | General Counsel |
Aug 19 '25 |
Sale |
3.00 |
588 |
1,762 |
135,462 |
5.74%
자본화:
|
볼륨(24시간):